Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform

As the sixth leading cause of cancer death, esophageal cancer is threatening the life of people worldwide. Traditional treatments, such as surgery, chemotherapy, radiotherapy, are facing always augmented challenges including invasion, multidrug resistance (MDR), off-target toxicity. Chemo &...

Full description

Bibliographic Details
Main Authors: Guodong Ren, ZiCheng Wang, Yafei Tian, Jinyao Li, Yingyu Ma, Liang Zhou, Chengwu Zhang, Lixia Guo, Haipeng Diao, Lihong Li, Li Lu, Sufang Ma, Zhifang Wu, Lili Yan, Wen Liu
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222008952
_version_ 1811214489400377344
author Guodong Ren
ZiCheng Wang
Yafei Tian
Jinyao Li
Yingyu Ma
Liang Zhou
Chengwu Zhang
Lixia Guo
Haipeng Diao
Lihong Li
Li Lu
Sufang Ma
Zhifang Wu
Lili Yan
Wen Liu
author_facet Guodong Ren
ZiCheng Wang
Yafei Tian
Jinyao Li
Yingyu Ma
Liang Zhou
Chengwu Zhang
Lixia Guo
Haipeng Diao
Lihong Li
Li Lu
Sufang Ma
Zhifang Wu
Lili Yan
Wen Liu
author_sort Guodong Ren
collection DOAJ
description As the sixth leading cause of cancer death, esophageal cancer is threatening the life of people worldwide. Traditional treatments, such as surgery, chemotherapy, radiotherapy, are facing always augmented challenges including invasion, multidrug resistance (MDR), off-target toxicity. Chemo & Photodynamic synergistic therapy represents one promising strategy for improved treatment efficiency. But it is still hindered by the lack of tumor targeting, deleterious side effects, and unfavorable microenvironment for photodynamic therapy (PDT). To overcome those obstacles, one theranostic nano-assambly drug, GCDs-Ce6/Pt-EGF, was designed and fabricated. Green fluorescence carbon dots (GCDs) with the excellent optical properties, modifiability and low toxicity were prepared as drug carrier. Epidermal growth factor (EGF) was conjugated to the nano-assembly to realize tumor specific targeting. Chlorin e6 (Ce6) in the presence of laser irradiation achieved PDT by generating proapoptosis reactive oxygen species (ROS). Moreover, Ce6 incorporated into GCDs endowed the nano-assambly imaging ability and facilitate image-guided therapy. Pt(IV), cisplatin prodrug, in the nano-assambly depleted the glutathione (GSH) of tumor microenvironment when it was reduced to cytotoxicity Pt(II). Compared with single treatment, GCDs-Ce6/Pt-EGF exhibited enhanced tumor cell killing capacity and better biosafety in vitro and in vivo, especially for EGFR bearing tumor. It paved ways for developing novel theranostic agent to be potentially applied in clinic.
first_indexed 2024-04-12T06:05:26Z
format Article
id doaj.art-cd7a261822f04149ac786b1d11fc0ac9
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-12T06:05:26Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-cd7a261822f04149ac786b1d11fc0ac92022-12-22T03:44:54ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-09-01153113506Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatformGuodong Ren0ZiCheng Wang1Yafei Tian2Jinyao Li3Yingyu Ma4Liang Zhou5Chengwu Zhang6Lixia Guo7Haipeng Diao8Lihong Li9Li Lu10Sufang Ma11Zhifang Wu12Lili Yan13Wen Liu14College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China; Key laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, PR China; Corresponding authors at: College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China.College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China; Key laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China; Corresponding author.College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaFirst school of clinical medicine, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR ChinaCollege of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China; First school of clinical medicine, Shanxi Medical University, Taiyuan 030001, PR China; Key laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, PR China; Corresponding authors at: College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, PR China.As the sixth leading cause of cancer death, esophageal cancer is threatening the life of people worldwide. Traditional treatments, such as surgery, chemotherapy, radiotherapy, are facing always augmented challenges including invasion, multidrug resistance (MDR), off-target toxicity. Chemo & Photodynamic synergistic therapy represents one promising strategy for improved treatment efficiency. But it is still hindered by the lack of tumor targeting, deleterious side effects, and unfavorable microenvironment for photodynamic therapy (PDT). To overcome those obstacles, one theranostic nano-assambly drug, GCDs-Ce6/Pt-EGF, was designed and fabricated. Green fluorescence carbon dots (GCDs) with the excellent optical properties, modifiability and low toxicity were prepared as drug carrier. Epidermal growth factor (EGF) was conjugated to the nano-assembly to realize tumor specific targeting. Chlorin e6 (Ce6) in the presence of laser irradiation achieved PDT by generating proapoptosis reactive oxygen species (ROS). Moreover, Ce6 incorporated into GCDs endowed the nano-assambly imaging ability and facilitate image-guided therapy. Pt(IV), cisplatin prodrug, in the nano-assambly depleted the glutathione (GSH) of tumor microenvironment when it was reduced to cytotoxicity Pt(II). Compared with single treatment, GCDs-Ce6/Pt-EGF exhibited enhanced tumor cell killing capacity and better biosafety in vitro and in vivo, especially for EGFR bearing tumor. It paved ways for developing novel theranostic agent to be potentially applied in clinic.http://www.sciencedirect.com/science/article/pii/S0753332222008952Esophageal cancerNano-assemblyEGFR targetingPhotodynamic therapyChemotherapy
spellingShingle Guodong Ren
ZiCheng Wang
Yafei Tian
Jinyao Li
Yingyu Ma
Liang Zhou
Chengwu Zhang
Lixia Guo
Haipeng Diao
Lihong Li
Li Lu
Sufang Ma
Zhifang Wu
Lili Yan
Wen Liu
Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
Biomedicine & Pharmacotherapy
Esophageal cancer
Nano-assembly
EGFR targeting
Photodynamic therapy
Chemotherapy
title Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
title_full Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
title_fullStr Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
title_full_unstemmed Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
title_short Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
title_sort targeted chemo photodynamic therapy toward esophageal cancer by gsh sensitive theranostic nanoplatform
topic Esophageal cancer
Nano-assembly
EGFR targeting
Photodynamic therapy
Chemotherapy
url http://www.sciencedirect.com/science/article/pii/S0753332222008952
work_keys_str_mv AT guodongren targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT zichengwang targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT yafeitian targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT jinyaoli targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT yingyuma targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT liangzhou targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT chengwuzhang targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT lixiaguo targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT haipengdiao targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT lihongli targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT lilu targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT sufangma targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT zhifangwu targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT liliyan targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform
AT wenliu targetedchemophotodynamictherapytowardesophagealcancerbygshsensitivetheranosticnanoplatform